{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:13:37Z","timestamp":1759342417749,"version":"3.44.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.amjmed.2003.08.026","type":"journal-article","created":{"date-parts":[[2004,2,23]],"date-time":"2004-02-23T15:14:09Z","timestamp":1077549249000},"page":"354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-term outcome of patients treated with he\u1e3fatopoietic growth factors for idiosyncratic drug-induced agranulocytosis"],"prefix":"10.1016","volume":"116","author":[{"given":"Emmanuel","family":"Andr\u00e8s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Noel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Maloisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2003.08.026_BIB1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0091-6749(98)70185-X","article-title":"The therapeutic use of hematopoietic growth factors","volume":"101","author":"Costa","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.amjmed.2003.08.026_BIB2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00062752-200105000-00005","article-title":"Safety of granulocyte-colony stimulating factor in normal donors","volume":"8","author":"Gutierrez-Delgado","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.amjmed.2003.08.026_BIB3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-9343(02)01064-1","article-title":"Non-chemotherapy drug-induced agranulocytosis in elderly patients","volume":"112","author":"Andr\u00e8s","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2003.08.026_BIB4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0953-6205(02)00085-7","article-title":"Modern management of non-chemotherapy drug- induced agranulocytosis","volume":"13","author":"Andr\u00e8s","year":"2002","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.amjmed.2003.08.026_BIB5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2796.2001.00915.x","article-title":"Acute and chronic neutropenias. What is new?","volume":"250","author":"Palmblad","year":"2001","journal-title":"J Intern Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934303005989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934303005989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:27:57Z","timestamp":1757579277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934303005989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0002934303005989"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2003.08.026","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcome of patients treated with he\u1e3fatopoietic growth factors for idiosyncratic drug-induced agranulocytosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2003.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}